Non-coding RNAs and glioma: Focus on cancer stem cells

Glioblastoma and gliomas can have a wide range of histopathologic subtypes. These heterogeneous histologic phenotypes originate from tumor cells with the distinct functions of tumorigenesis and self-renewal, called glioma stem cells (GSCs). GSCs are characterized based on multi-layered epigenetic me...

Full description

Bibliographic Details
Main Authors: Ali Rajabi, Mehrdad Kayedi, Shiva Rahimi, Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Mina Homayoonfal, Seyed Mohammad Amin Mahdian, Michael R. Hamblin, Omid Reza Tamtaji, Ali Afrasiabi, Ameneh Jafari, Hamed Mirzaei
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Molecular Therapy: Oncolytics
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2372770522001176
_version_ 1811250645000257536
author Ali Rajabi
Mehrdad Kayedi
Shiva Rahimi
Fatemeh Dashti
Seyed Mohammad Ali Mirazimi
Mina Homayoonfal
Seyed Mohammad Amin Mahdian
Michael R. Hamblin
Omid Reza Tamtaji
Ali Afrasiabi
Ameneh Jafari
Hamed Mirzaei
author_facet Ali Rajabi
Mehrdad Kayedi
Shiva Rahimi
Fatemeh Dashti
Seyed Mohammad Ali Mirazimi
Mina Homayoonfal
Seyed Mohammad Amin Mahdian
Michael R. Hamblin
Omid Reza Tamtaji
Ali Afrasiabi
Ameneh Jafari
Hamed Mirzaei
author_sort Ali Rajabi
collection DOAJ
description Glioblastoma and gliomas can have a wide range of histopathologic subtypes. These heterogeneous histologic phenotypes originate from tumor cells with the distinct functions of tumorigenesis and self-renewal, called glioma stem cells (GSCs). GSCs are characterized based on multi-layered epigenetic mechanisms, which control the expression of many genes. This epigenetic regulatory mechanism is often based on functional non-coding RNAs (ncRNAs). ncRNAs have become increasingly important in the pathogenesis of human cancer and work as oncogenes or tumor suppressors to regulate carcinogenesis and progression. These RNAs by being involved in chromatin remodeling and modification, transcriptional regulation, and alternative splicing of pre-mRNA, as well as mRNA stability and protein translation, play a key role in tumor development and progression. Numerous studies have been performed to try to understand the dysregulation pattern of these ncRNAs in tumors and cancer stem cells (CSCs), which show robust differentiation and self-regeneration capacity. This review provides recent findings on the role of ncRNAs in glioma development and progression, particularly their effects on CSCs, thus accelerating the clinical implementation of ncRNAs as promising tumor biomarkers and therapeutic targets.
first_indexed 2024-04-12T16:07:45Z
format Article
id doaj.art-21898c45f3aa42d3b9f56172b39fe192
institution Directory Open Access Journal
issn 2372-7705
language English
last_indexed 2024-04-12T16:07:45Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series Molecular Therapy: Oncolytics
spelling doaj.art-21898c45f3aa42d3b9f56172b39fe1922022-12-22T03:25:59ZengElsevierMolecular Therapy: Oncolytics2372-77052022-12-0127100123Non-coding RNAs and glioma: Focus on cancer stem cellsAli Rajabi0Mehrdad Kayedi1Shiva Rahimi2Fatemeh Dashti3Seyed Mohammad Ali Mirazimi4Mina Homayoonfal5Seyed Mohammad Amin Mahdian6Michael R. Hamblin7Omid Reza Tamtaji8Ali Afrasiabi9Ameneh Jafari10Hamed Mirzaei11School of Medicine, Kashan University of Medical Sciences, Kashan, Iran; Student Research Committee, Kashan University of Medical Sciences, Kashan, IranDepartment of Radiology, Shiraz University of Medical Sciences, Shiraz, IranSchool of Medicine,Fasa University of Medical Sciences, Fasa, IranSchool of Medicine, Kashan University of Medical Sciences, Kashan, Iran; Student Research Committee, Kashan University of Medical Sciences, Kashan, IranSchool of Medicine, Kashan University of Medical Sciences, Kashan, Iran; Student Research Committee, Kashan University of Medical Sciences, Kashan, IranResearch Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, IranDepartment of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IranLaser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein 2028, South AfricaElectrophysiology Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran; Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Internal Medicine, Iran University of Medical Sciences, Tehran, Iran; Corresponding author Ali Afrasiabi, Department of Internal Medicine, Iran university of medical sciences, Tehran, Iran.Advanced Therapy Medicinal Product (ATMP) Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran; Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Corresponding author Ameneh Jafari, Advanced Therapy Medicinal Product (ATMP) Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran; Corresponding author Hamed Mirzaei, Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran.;Glioblastoma and gliomas can have a wide range of histopathologic subtypes. These heterogeneous histologic phenotypes originate from tumor cells with the distinct functions of tumorigenesis and self-renewal, called glioma stem cells (GSCs). GSCs are characterized based on multi-layered epigenetic mechanisms, which control the expression of many genes. This epigenetic regulatory mechanism is often based on functional non-coding RNAs (ncRNAs). ncRNAs have become increasingly important in the pathogenesis of human cancer and work as oncogenes or tumor suppressors to regulate carcinogenesis and progression. These RNAs by being involved in chromatin remodeling and modification, transcriptional regulation, and alternative splicing of pre-mRNA, as well as mRNA stability and protein translation, play a key role in tumor development and progression. Numerous studies have been performed to try to understand the dysregulation pattern of these ncRNAs in tumors and cancer stem cells (CSCs), which show robust differentiation and self-regeneration capacity. This review provides recent findings on the role of ncRNAs in glioma development and progression, particularly their effects on CSCs, thus accelerating the clinical implementation of ncRNAs as promising tumor biomarkers and therapeutic targets.http://www.sciencedirect.com/science/article/pii/S2372770522001176MT: Non-coding RNAsGliomaCancer stem cells
spellingShingle Ali Rajabi
Mehrdad Kayedi
Shiva Rahimi
Fatemeh Dashti
Seyed Mohammad Ali Mirazimi
Mina Homayoonfal
Seyed Mohammad Amin Mahdian
Michael R. Hamblin
Omid Reza Tamtaji
Ali Afrasiabi
Ameneh Jafari
Hamed Mirzaei
Non-coding RNAs and glioma: Focus on cancer stem cells
Molecular Therapy: Oncolytics
MT: Non-coding RNAs
Glioma
Cancer stem cells
title Non-coding RNAs and glioma: Focus on cancer stem cells
title_full Non-coding RNAs and glioma: Focus on cancer stem cells
title_fullStr Non-coding RNAs and glioma: Focus on cancer stem cells
title_full_unstemmed Non-coding RNAs and glioma: Focus on cancer stem cells
title_short Non-coding RNAs and glioma: Focus on cancer stem cells
title_sort non coding rnas and glioma focus on cancer stem cells
topic MT: Non-coding RNAs
Glioma
Cancer stem cells
url http://www.sciencedirect.com/science/article/pii/S2372770522001176
work_keys_str_mv AT alirajabi noncodingrnasandgliomafocusoncancerstemcells
AT mehrdadkayedi noncodingrnasandgliomafocusoncancerstemcells
AT shivarahimi noncodingrnasandgliomafocusoncancerstemcells
AT fatemehdashti noncodingrnasandgliomafocusoncancerstemcells
AT seyedmohammadalimirazimi noncodingrnasandgliomafocusoncancerstemcells
AT minahomayoonfal noncodingrnasandgliomafocusoncancerstemcells
AT seyedmohammadaminmahdian noncodingrnasandgliomafocusoncancerstemcells
AT michaelrhamblin noncodingrnasandgliomafocusoncancerstemcells
AT omidrezatamtaji noncodingrnasandgliomafocusoncancerstemcells
AT aliafrasiabi noncodingrnasandgliomafocusoncancerstemcells
AT amenehjafari noncodingrnasandgliomafocusoncancerstemcells
AT hamedmirzaei noncodingrnasandgliomafocusoncancerstemcells